Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments: 2021-2025

Historic Change in Acquisitions & Divestments for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $84.1 million.

  • Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments rose 74.67% to $84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.2 million, marking a year-over-year increase of 24.06%. This contributed to the annual value of $239.9 million for FY2024, which is 36.71% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Change in Acquisitions & Divestments of $84.1 million as of Q3 2025, which was up 174.71% from $30.6 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments registered a high of $139.2 million during Q1 2021, and its lowest value of $7.5 million during Q1 2022.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments had a median value of $46.0 million in 2023 and averaged $52.2 million.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments tumbled by 94.61% in 2022, and later spiked by 312.56% in 2024.
  • Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $10.0 million in 2021, then spiked by 101.00% to $20.1 million in 2022, then spiked by 128.75% to $46.0 million in 2023, then spiked by 90.26% to $87.5 million in 2024, then spiked by 74.67% to $84.1 million in 2025.
  • Its last three reported values are $84.1 million in Q3 2025, $30.6 million for Q2 2025, and $44.0 million during Q1 2025.